摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-bromo-2-hydroxy-benzylidene)-malonic acid | 854847-10-2

中文名称
——
中文别名
——
英文名称
(5-bromo-2-hydroxy-benzylidene)-malonic acid
英文别名
(5-Brom-2-hydroxy-benzyliden)-malonsaeure;2-[(5-Bromo-2-hydroxyphenyl)methylidene]propanedioic acid
(5-bromo-2-hydroxy-benzylidene)-malonic acid化学式
CAS
854847-10-2
化学式
C10H7BrO5
mdl
——
分子量
287.067
InChiKey
LDNMZYNRJWFXCB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    94.8
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF
    申请人:SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC.
    公开号:US20150239861A1
    公开(公告)日:2015-08-27
    The present invention relates to a compound as represented by formula (I), which is a condensation product of a theanine derivative and a carboxylic acid coumarin derivative, compounds as represented by formula (II) and formula (III), both of which are intermediates of the condensation product, a method for preparing these compounds, a pharmaceutical composition comprising the compounds, and a use thereof in preparing a medicament for prevention and treatment of tumors, inflammation, cardiovascular diseases, immune deficiency diseases and the like. Wherein, (Ia) R═CH 3 R 1 ═H R 2 ═H (Ib) R═CH 2 CH 3 R 1 ═H R 2 ═H (Ic) R═CH 2 CH 3 R 1 ═Cl R 2 ═H (Id) R═CH 2 CH 3 R 1 ═Br R 2 ═H (Ie) R═CH 2 CH 3 R 1 ═F R 2 ═H (If) R═CH 2 CH 3 R 1 ═NO 2 R 2 ═H (Ig) R═CH 2 CH 3 R 1 ═Cl R 2 ═Cl (Ih) R═CH 2 CH 3 R 1 ═Br R 2 ═Br (Ii) R═CH 2 CH 3 R 1 ═NH 2 R 2 ═H Wherein, (IIa) R═CH 3 (IIb) R═CH 2 CH 3 Wherein, (IIIc) R 1 ═Cl R 2 ═H (IIId) R 1 ═Br R 2 ═H (IIIe) R 1 ═F R 2 ═H (IIIf) R 1 ═NO 2 R 2 ═H (IIIg) R 1 ═Cl R 2 ═Cl (IIIh) R 1 ═Br R 2 ═Br
    本发明涉及一种由茶氨酸生物羧酸香豆素生物缩合而成的式(I)化合物,以及式(II)和式(III)化合物,它们都是缩合产物的中间体,制备这些化合物的方法,包含这些化合物的药物组合物,以及它们在制备预防和治疗肿瘤、炎症、心血管疾病、免疫缺陷病等药物中的用途。其中,(Ia)R = CH3,R1 = H,R2 = H;(Ib)R = CH2 ,R1 = H,R2 = H;(Ic)R = CH2 ,R1 = Cl,R2 = H;(Id)R = CH2 ,R1 = Br,R2 = H;(Ie)R = CH2 ,R1 = F,R2 = H;(If)R = CH2 ,R1 = NO2,R2 = H;(Ig)R = CH2 ,R1 = Cl,R2 = Cl;(Ih)R = CH2 ,R1 = Br,R2 = Br;(Ii)R = CH2 ,R1 = NH2,R2 = H。其中,(IIa)R = ;(IIb)R = CH2 。其中,(IIIc)R1 = Cl,R2 = H;(IIId)R1 = Br,R2 = H;(IIIe)R1 = F,R2 = H;(IIIf)R1 = ,R2 = H;(IIIg)R1 = Cl,R2 = Cl;(IIIh)R1 = Br,R2 = Br。
  • CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF
    申请人:Yantai University
    公开号:EP2902388A1
    公开(公告)日:2015-08-05
    The present invention relates to a compound as represented by formula (I), which is a condensation product of a theanine derivative and a carboxylic acid coumarin derivative, compounds as represented by formula (II) and formula (III), both of which are intermediates of the condensation product, a method for preparing these compounds, a pharmaceutical composition comprising the compounds, and a use thereof in preparing a medicament for prevention and treatment of tumors, inflammation, cardiovascular diseases, immune deficiency diseases and the like. Wherein, Wherein, Wherein.
    本发明涉及一种由式(I)表示的化合物,它是一种茶氨酸生物和一种羧酸香豆素生物的缩合产物;由式(II)和式(III)表示的化合物,它们都是该缩合产物的中间体;一种制备这些化合物的方法;一种包含这些化合物的药物组合物;以及其在制备预防和治疗肿瘤、炎症、心血管疾病、免疫缺陷疾病等的药物中的用途。 其中, 其中, 其中, 其中。
  • US9518038B2
    申请人:——
    公开号:US9518038B2
    公开(公告)日:2016-12-13
查看更多